Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.288,18
-0,70%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Madrigal Pharmaceuticals Inc (MDGL) Madrigal Pharmaceuticals Inc (MDGL) Notizie

Madrigal Pharmaceuticals Inc

MDGL
193,00
-1,38 (-0,71%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/4/202422:00GLOBEMadrigal Statement on the Passing of Dr. Stephen Harrison
23/4/202414:00GLOBEMadrigal Pharmaceuticals to Release First-Quarter 2024..
16/4/202422:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
09/4/202414:00GLOBEMadrigal Pharmaceuticals Announces U.S. Availability of..
03/4/202422:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
19/3/202404:58GLOBEMadrigal Pharmaceuticals Announces Pricing of Upsized $600..
18/3/202421:04GLOBEMadrigal Pharmaceuticals Announces Proposed Public Offering
15/3/202412:30IHMARKETNEWSAdobe Stock Drops Following Below-Estimate Projections,..
14/3/202421:15GLOBEMadrigal Pharmaceuticals Announces FDA Approval of..
06/3/202422:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
05/3/202414:00GLOBEMadrigal Pharmaceuticals Announces EMA Validation of its..
28/2/202413:10EDGAR2Form 8-K - Current report
28/2/202413:01EDGAR2Form 8-K - Current report
28/2/202413:01GLOBEMadrigal Pharmaceuticals Appoints Mardi C. Dier as Chief..
28/2/202413:00GLOBEMadrigal Pharmaceuticals Provides Corporate Updates and..
28/2/202412:32EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/2/202414:00GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
14/2/202420:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202423:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202414:00GLOBEMadrigal Pharmaceuticals Announces Publication of the Phase..
06/2/202422:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
29/1/202414:00GLOBEMadrigal Pharmaceuticals Announces Additions to Its..
26/1/202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202421:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202421:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202421:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202414:00GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
18/1/202419:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202419:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202419:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202419:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202419:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202419:45EDGAR2Form 8-K - Current report
04/1/202414:00GLOBEMadrigal Pharmaceuticals Presents Five Health Economics..
03/1/202422:30GLOBEMadrigal Pharmaceuticals to Present at the 42nd Annual J.P...
22/12/202322:30GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
18/12/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:05EDGAR2Form SC 13D/A - General statement of acquisition of..
06/12/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202322:30GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
22/11/202323:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202323:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/11/202323:24EDGAR2Form SC 13D/A - General statement of acquisition of..
21/11/202314:00GLOBEMadrigal Pharmaceuticals Appoints Ronald Filippo as Chief..
15/11/202322:45GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
Apertura: 192,49 Min: 189,00 Max: 195,58
Chiusura: 194,38

La tua Cronologia

NASDAQ
MDGL
Madrigal Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network